ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Myeloid-derived suppressor cells promote tumor growth and sorafenib resistance by inducing FGF1 upregulation and fibrosis

Deng, Xue; Li, Xueyan; Guo, Xuan; Lu, Yantong; Xie, Yingjie; Huang, Xuhui; Lin, Juze; Tan, Wei; Wang, Changjun*广东省人民医院; 广州中医药大学; 南方医科大学
Neoplasia2022-6DOI: 10.1016/j.neo.2022.100788
16被引12阅读
引用收藏
分享

摘要

Background @@@ Considerable evidence implicates myeloid-derived suppressor cells (MDSCs) promote tumor progression and drug resistance. Sorafenib is the standard first-line therapy for advanced hepatocellular carcinoma (HCC). Clinical evidence indicates that sorafenib resistance is associated with increased MDSCs, by which MDSCs exerts these effects is obscure. This study aimed to investigate the mechanism of sorafenib resistance mediated by MDSCs. @@@ Methods @@@ A syngeneic mouse-liver cancer cell line BNL was subcutaneously injected to build a tumor-bearing mouse model, and syngeneic MDSCs were adoptive transferred into the tumor-bearing mouse. Tumor tissue was obtained, and transcriptomic analysis of the tumor was carried out on RNAseq data. A coculture system was used to verify the crosstalk between MDSCs and BNL cells. @@@ Results Adoptive MDSCs transfer into tumor-bearing mice induced an increase of tumor-infiltrating MDSCs, which led to tumor growth and impaired antitumor activity of sorafenib in BNL HCC models. MDSCs transfer contributed to tumor fibrosis and tumor-associated fibroblast (CAF) activation, associated with fibroblast growth factor (FGF1) upregulation. In contrast, MDSC depletion by antiLy6G+ reduced fibrosis and increased sorafenib antitumor efficacy. Intriguingly, tumor-infiltrating MDSCs barely expressed FGF1. IL-6 derived from MDSCs increased FGF1 expression in BNL liver cancer cells, and anti-IL-6 attenuated this effect in vitro . MAPK pathway, one of the sorafenib targets, is the downstream signaling of FGF1 and is reactivated by MDSCs-mediated FGF1 upregulation. @@@ Conclusions Our finding demonstrated that MDSCs led to tumor growth and sorafenib resistance via FGF1 upregulation and subsequent indirect CAF activation. We offered a novel mechanism of MDSCs-driven HCC progression and sorafenib resistance.

学科与关键词

关键词
Myeloid cellsHepatocellular carcinomaSorafenibFibroblast cellsCombination therapy
相关
加载中…
  • KDM5B regulates the PTEN/PI3K/Akt pathway to increase sorafenib-resistance in hepatocellular carcinoma
    Liu, Jia; Nie, Chunsheng*Anti-Cancer Drugs, 2022, 33(9): 840-849.被引 6
  • MYBL1 induces transcriptional activation of ANGPT2 to promote tumor angiogenesis and confer sorafenib resistance in human hepatocellular carcinoma
    Zhu, Jinrong; Wu, Yongqi; Yu, Yijian; Li, Yan; Shen, Jianfei*; Zhang, Rongxin*Cell Death & Disease, 2022, 13(8): 727.被引 9
  • Targeting Myeloid-Derived Suppressor Cells to Enhance the Antitumor Efficacy of Immune Checkpoint Blockade Therapy
    Li, Xueyan; Zhong, Jiahui; Deng, Xue; Guo, Xuan; Lu, Yantong; Lin, Juze; Huang, Xuhui*; Wang, Changjun*Frontiers in Immunology, 2021, 12: 754196.被引 13
查看全部 →

发表信息

论文状态
公开发表
期刊
Neoplasia
发表日期
2022-06
卷期
第 28 卷
页码
100788
DOI
10.1016/j.neo.2022.100788
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81774261]; Science and Technology Program of Guangzhou [202102080232]

作者

  • D

    Deng, Xue (第一作者)

    guangdong prov peoples hosp · southern med univ

  • L

    Li, Xueyan

    southern med univ · guangdong prov peoples hosp

查看全部 9 位作者收起作者
  • G

    Guo, Xuan

    guangdong prov peoples hosp

  • L

    Lu, Yantong

    guangzhou univ chinese med · guangdong prov peoples hosp

  • X

    Xie, Yingjie

  • H

    Huang, Xuhui

    guangdong prov peoples hosp

  • L

    Lin, Juze

    guangdong prov peoples hosp

  • T

    Tan, Wei

    guangdong prov peoples hosp

  • W

    Wang, Changjun (通讯)

    southern med univ · guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417